Ascletis Pharma announces first dosing of HBV patient in ASC22 trial
China | News | 0 Comment | 17 Aug, 2020
China-based Ascletis Pharma Inc. recently announced the dosing of the first HBV patient in Phase IIa clinical trial of A...Read more
CUHK study suggests Hot Nights pose greater threat to public health than Hot Days
China | News | 0 Comment | 17 Aug, 2020
Hong Kong has been experiencing hotter summers and more scorcher days in recent years due to climate change and heat isl...Read more
CanSinoBIO lists successfully on STAR Market as Initial dual listing vaccine company
China | News | 0 Comment | 14 Aug, 2020
China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...Read more
Viva Biotech acquires major stake in Chinese CDMO
China | News | 0 Comment | 14 Aug, 2020
Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...Read more
Antengene announces approval of first Ph I Trial of ATG-017
China | News | 0 Comment | 13 Aug, 2020
Shanghai-based Antengene Corporation, leading innovative hematology and oncology-focused biopharmaceutical company, anno...Read more
SCMP’s China Healthcare Report reveals World’s Second-Largest Healthcare Market
China | News | 0 Comment | 13 Aug, 2020
South China Morning Post announced on 13 August 2020 the release of its inaugural China Healthcare Report that...Read more
Innovent & Lilly announce acceptance of new drug application for TYVYT® (sintilimab injection)
China | News | 0 Comment | 12 Aug, 2020
China-based Innovent Biologics, Inc. (Innovent), jointly announced with Eli Lilly and Company (Lilly) that the National ...Read more
LianBio to extend cutting-edge therapeutics in China and major Asian market
China | News | 0 Comment | 12 Aug, 2020
LianBio, founded, seeded and incubated by Perceptive Advisors, announced its launch on 11 August 2020 with a diverse arr...Read more
Asclepius Meditec's hydrogen/oxygen generator helps improve COVID-19 severity
China | News | 0 Comment | 11 Aug, 2020
An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, inv...Read more
Hong Kong discovers liver injury in COVID-19 patients
China | News | 0 Comment | 12 Aug, 2020
Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a ...Read more
Innovent & Lilly release clinical trial results of sintilimab injection
China | News | 0 Comment | 10 Aug, 2020
China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...Read more
Regulations and geopolitics themes for Japanese companies to reduce dependence on China
China | Analysis | 0 Comment | 07 Aug, 2020
Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...Read more
ImmVira, Shanghai Pharma to commercialize novel immunotherapies
China | News | 1 Comment | 07 Aug, 2020
ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...Read more
AstraZeneca inks COVID-19 vaccine deal with China's BioKangtai
China | News | 0 Comment | 07 Aug, 2020
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...Read more
HBM collaborates with Viva Biotech to promote biotech start-ups
China | News | 0 Comment | 05 Aug, 2020
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...Read more
G1, Simcere to bring new cancer therapy in Greater China
China | News | 0 Comment | 06 Aug, 2020
US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more
Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody
China | News | 0 Comment | 03 Aug, 2020
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more
Gan & Lee launches first Ph I clinical trial for new anti-tumor drug
China | News | 0 Comment | 31 Jul, 2020
Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...Read more